Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2259 of 5804
-
Hypnosis may ease breathlessness without drugs
Symptom relief Recruiting nowPersistent dyspnea is a debilitating symptom, that is common and difficult to treat. This symptom is found in many different diseases including chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), chronic heart failure (CHF), and metastatic cancer. Dyspn…
Phase: NA • Sponsor: University Hospital, Geneva • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Spit and blood may predict who benefits from lung cancer immunotherapy
Knowledge-focused Not yet recruitingLung cancer is the leading cause of cancer-related death worldwide, with nearly 2.48 million cases and 1.8 million deaths in 2022. Despite therapeutic progress, late diagnosis and high mortality make it a major public health issue. Immune checkpoint inhibitors (ICI) such as nivol…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could vitamin B3 save sight in rare genetic blindness?
Disease control Not yet recruitingLeber Hereditary Optic Neuropathy (LHON) is a rare genetic disease that causes sudden and severe vision loss, usually in young adults. It is linked to mutations in mitochondrial DNA that impair energy production in retinal ganglion cells, leading to degeneration of the optic nerv…
Phase: PHASE1 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a head zapper ease tough pain syndrome?
Symptom relief Recruiting nowTranscranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profi…
Phase: NA • Sponsor: Polyclinique de l'Europe • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a quick dose of dapagliflozin help elderly heart failure patients in the ER?
Disease control Not yet recruitingBackground: SGLT2 inhibitors reduce CHF morbidity/mortality but are underutilized in elderly patients with acute decompensated CHF (ADCHF) admitted outside cardiology departments. Objective: Assess feasibility of early ED-initiated gliflozin therapy in elderly ADCHF patients. D…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Herbal hope for tics: new study tests ancient formula on kids
Disease control Recruiting nowTourette Syndrome (TS) children were administered Pei Tu Ning Feng Tang treatment. The differences in gut microbiota composition, peripheral blood stress hormones, oxidative stress markers, cytokines, neurotransmitters, and hair cortisol concentrations were observed before and af…
Phase: NA • Sponsor: Dongdong Qin • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Virtual reality tested as a new way to improve balance in seniors
Symptom relief Not yet recruitingAccording to demographic projections, by 2040, a quarter of the French population will be over 65. In this age group, the quality and quantity of visual, somaesthetic and vestibular information decline. This weakening of the balancing and the recurrence of falls lead to a restric…
Phase: NA • Sponsor: Hopital Nord Franche-Comte • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could group doctor visits help control chronic disease in nepal?
Disease control Not yet recruitingHypertension and diabetes represent significant and growing public health challenges in Nepal, particularly in underserved communities. Traditional individual-based care approaches may not adequately address the multifaceted needs of patients with these chronic conditions in reso…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Weight loss drug plus exercise may protect muscle in women
Disease control Recruiting nowThis study aims to investigate the effect that a structured, progressive resistance exercise program may have on maintaining the muscle mass and physical function of overweight/ obese females whilst they experience a tirzepatide (GLP-1/GIP receptor agonist) induced weight loss. …
Phase: NA • Sponsor: University of Exeter • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blood thinner apixaban tested for late clots after spleen surgery
Disease control Recruiting nowThe purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after laparoscopic splenectomy and azygoportal disconnection.
Phase: NA • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can stem cell exosomes reverse facial aging? new trial aims to find out
Symptom relief Not yet recruitingThis study aims to evaluate the potential effects of mesenchymal stem cell-derived suspended exosome therapy on facial skin quality using objective imaging analysis. Thirty adult participants will receive intradermal exosome applications in three treatment sessions performed at o…
Phase: PHASE3 • Sponsor: Mert Ersan • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Acupuncture needles take on heart flutters: new trial tests ancient therapy after ablation
Disease control Not yet recruitingThis study aims to evaluate whether acupuncture can reduce the recurrence of atrial arrhythmias after catheter ablation in patients with persistent atrial fibrillation. Catheter ablation is an effective treatment for atrial fibrillation, but recurrence remains common, especially …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Blood test may spot lupus kidney damage early, reducing need for biopsies
Diagnosis Not yet recruitingLupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SLE) patients and remains a leading cause of morbidity, with 10-30% progressing to end-stage renal disease within 15 years. The International Society of Nephrology/Renal Pathology Society (ISN/RPS) classifie…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Virtual doppelgänger may help pick right patients for kidney nerve treatment
Knowledge-focused Not yet recruitingHigh blood pressure (hypertension) is a common condition. Despite the availability of several medications, many patients continue to have poorly controlled blood pressure. Renal denervation (RDN), a minimally invasive procedure that reduces overactive kidney nerves, has emerged a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Frisbee players get a Game-Changing rehab for shoulder pain
Symptom relief Recruiting nowScapular dyskinesia (SD) is a disorder defined by aberrant scapular placement and movement, which can have a substantial impact on athletes' performance, particularly those who participate in throwing sports like Frisbee. This study aims to investigate the prevalence of SD among …
Phase: NA • Sponsor: INTI International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Glow-in-the-dark dye could help surgeons find hidden cancers
Diagnosis Recruiting nowThis study is evaluating whether a medication called 5-aminolevulinic acid (5-ALA), approved by the FDA for use in brain surgery, can help improve the visibility of upper tract urothelial tumors during surgery. Patients undergoing ureteroscopic tumor resection will receive 5-ALA …
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New drug cocktail aims to cut Post-Surgery pain in half
Symptom relief Not yet recruitingSpinal surgery is generally followed by severe postoperative pain, and poor pain control may cause adverse outcomes such as cardiovascular events, neurocognitive disorders, and chronic postsurgical pain (CPSP). In previous studies, perioperative use of dexmedetomidine or esketami…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Digital lifestyle program aims to ease migrant mental health struggles
Symptom relief Not yet recruitingMigrant populations experience elevated levels of psychological distress while facing barriers to accessing mental health care. Lifestyle factors such as physical activity, sleep, diet, and social engagement are closely linked to mental health and represent promising targets for …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dutch researchers check if weight-loss drug lives up to hype in real-world clinics
Knowledge-focused Not yet recruitingTirzepatide is one of the new medications for the treatment of obesity. In clinical research people treated with Tirzepatide have weight loss up to 21%. But there is only a little bit of research showing the effect of Tirzepatide in clinical practice. In this retrospective obser…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New Touch-Free laser offers hope for glaucoma patients who need a second treatment
Disease control Not yet recruitingThis study looks at a new laser treatment for people with high eye pressure or a type of glaucoma called open-angle glaucoma. All patients in the study have already had a similar laser treatment before (called SLT). In this study, everyone will receive the same treatment, called …
Phase: NA • Sponsor: The New York Eye Surgery Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC